Anticoagulant Citrate Dextrose A Solution
NDC Package 23731-6051-2
Package Information
Anticoagulant Citrate Dextrose A (anhydrous citric acid, dextrose monohydrate, and trisodium citrate dihydrate) solution is anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. This formulation utilizes a solution delivery system. Marketed by Citra Labs Llc, this product is identified by NDC 23731-6051 and is authorized under FDA application BN020037.
Identification & Billing
Clinical Specifications
- Acidifying Activity - [MoA] (Mechanism of Action)
- Acidifying Activity - [MoA] (Mechanism of Action)
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 23731 - Citra Labs Llc
- 23731-6051 - Anticoagulant Citrate Dextrose A
- 23731-6051-2 - 25 VIAL, SINGLE-USE in 1 CASE / 30 mL in 1 VIAL, SINGLE-USE (23731-6051-3)
- 23731-6051 - Anticoagulant Citrate Dextrose A
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (23731-6051). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 23731-6051-2 identifies a specific commercial package of 25 vial, single-use in 1 case / 30 ml in 1 vial, single-use (23731-6051-3) of Anticoagulant Citrate Dextrose A, a human prescription drug labeled by Citra Labs Llc. This solution is formulated for extracorporeal use and contains anhydrous citric acid; dextrose monohydrate; trisodium citrate dihydrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Citra Labs Llc on August 26, 2003. The current certification is valid through December 31, 2026.
How is this Citra Labs Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 23731605102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.